English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2362]
News [4951]
Articles [204]
Editorials [8]
Conferences [138]
elearning [14]
Primary care physicians and urologists work together to provide optimal care for men with low-risk prostate cancer
Primary care physicians and urologists work together to provide optimal care for men with low-risk prostate cancer
FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma
FDA approves erdafitinib for locally advanced or metastatic urothelial carcinoma
ASCO GI 2024: New immunotherapy combinations for patients with oesophageal cancer
ASCO GI 2024: New immunotherapy combinations for patients with oesophageal cancer
ASCO GI 2024: New study adds to ambiguity of role of post-operative ctDNA to guide treatment in patients with low-risk, stage IIA colon cancer
ASCO GI 2024: New study adds to ambiguity of role of post-operative ctDNA to guide treatment in patients with low...
CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies
CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies
AI harnesses tumour genetics to predict treatment response
AI harnesses tumour genetics to predict treatment response
Ageing in cells may boost ovarian cancer spread
Ageing in cells may boost ovarian cancer spread
Aberrant RBMX expression relevant for cancer prognosis and immunotherapy response
Aberrant RBMX expression relevant for cancer prognosis and immunotherapy response
ATR inhibition using gartisertib in patient-derived glioblastoma cell lines
ATR inhibition using gartisertib in patient-derived glioblastoma cell lines
Bladder tumours reduced by 90% using nanorobots
Bladder tumours reduced by 90% using nanorobots
<1...5556575859...496>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top